AMGEN INC Long-Term Debt

Quick Answer

AMGEN INC reported Long-Term Debt of $50.01 billion for fiscal year 2025.

AMGEN INC Long-Term Debt — Annual History

Fiscal Year Long-Term Debt YoY Change
2025 $50.01B -11.6%
2024 $56.55B -10.5%
2023 $63.17B +69.1%
2022 $37.35B +12.4%
2021 $33.22B +1.0%
2020 $32.90B +22.1%
2019 $26.95B -8.7%
2018 $29.51B -13.7%
2017 $34.19B +13.2%
2016 $30.19B +3.5%
2015 $29.18B -3.4%
2014 $30.21B +2.0%
2013 $29.62B

Quarterly Long-Term Debt

Quarter Ending Long-Term Debt YoY QoQ
September 30, 2025 $52.43B -7.8% -2.5%
June 30, 2025 $53.76B -5.9% -0.5%
March 31, 2025 $54.01B -10.1% -4.5%
December 31, 2024 $56.55B -10.5% -0.5%
September 30, 2024 $56.85B -3.7% -0.5%
June 30, 2024 $57.12B -3.8% -4.9%
March 31, 2024 $60.06B -1.2% -4.9%
December 31, 2023 $63.17B +69.1% +7.0%
  • AMGEN INC showed a decrease of -11.6% in Long-Term Debt compared to the prior fiscal year.
  • Over the 2013–2025 period, AMGEN INC’s long-term debt has grown by 68.8% (from $29.62 billion to $50.01 billion).
  • The most recent figure is from AMGEN INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment